CSF biomarkers of Alzheimer's disease concord with amyloid‐β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts

Hansson, Oskar, Seibyl, John, Stomrud, Erik, Zetterberg, Henrik, Trojanowski, John Q., Bittner, Tobias, Lifke, Valeria, Corradini, Veronika +9 more·2018·Alzheimer's & Dementia

DOI 10.1016/j.jalz.2018.01.010

Cited by (809)

Items 301–400 of 809

Attention-Guided Deep Graph Neural Network for Longitudinal Alzheimer’s Disease Analysis
Junbo Ma, Xiaofeng Zhu, Defu Yang, Jiazhou Chen, Guorong Wu A · 2020 · Lecture notes in computer science
Prognostic Role of CSF β-amyloid 1–42/1–40 Ratio in Patients Affected by Amyotrophic Lateral Sclerosis
Tiziana Colletti, Luisa Agnello, Rossella Spataro, Lavinia Guccione, Antonietta Notaro, Bruna Lo Sasso, Valeria Blandino, Fabiola Graziano, Caterina Maria Gambino, Rosaria Vincenza Giglio et al. · 2021 · Brain Sciences
Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease
Anika Wuestefeld, Alexa Pichet Binette, Danielle van Westen, Olof T. Strandberg, Erik Stomrud, Niklas Mattsson, Shorena Janelidze, Ruben A Smith, Sebastian Palmqvist, Hannah Baumeister et al. · 2024 · Alzheimer s Research & Therapy
Imaging and Fluid Biomarkers of Alzheimer Disease: Complementation Rather Than Competition
Alexander E. Drzezga, Henryk Barthel · 2025 · Journal of Nuclear Medicine
Associations of Alcohol Consumption with Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease Pathology in Cognitively Intact Older Adults: The CABLE Study
Zuo-Teng Wang, Kunyan Li, Chen‐Chen Tan, Wei Xu, Xue‐Ning Shen, Xi‐Peng Cao, Ping Wang, Yanlin Bi, Qiang Dong, Lan Tan et al. · 2021 · Journal of Alzheimer s Disease
Longitudinal changes in metabolic network activity in early Alzheimer's disease
Matej Perovnik, Chris C. Tang, Mauro Namías, David Eidelberg, Alzheimer’s Disease Neuroimaging Initiative · 2023 · Alzheimer s & Dementia
Towards cascading genetic risk in Alzheimer’s disease
Altmann, Andre, Aksman, Leon M, Oxtoby, Neil P, Young, Alexandra L, ADNI, Weiner, Michael, Aisen, Paul, Petersen, Ronald, Weiner, Michael, Aisen, Paul et al. · 2024 · Brain
Comparison of deep learning architectures for predicting amyloid positivity in Alzheimer’s disease, mild cognitive impairment, and healthy aging, from T1-weighted brain structural MRI
Tamoghna Chattopadhyay, Saket S. Ozarkar, Ketaki Buwa, Neha Ann Joshy, Dheeraj Komandur, Jayati Naik, Sophia I. Thomopoulos, Greg Ver Steeg, José Luis Ambite, Paul M. Thompson · 2024 · Frontiers in Neuroscience
Amyloid PET detects the deposition of brain Aβ earlier than CSF fluid biomarkers
Val J. Lowe, Carly T. Mester, Emily S. Lundt, Jeyeon Lee, Sujala Ghatamaneni, Alicia Algeciras‐Schimnich, Michelle Renee Campbell, Jonathan Graff‐Radford, Aivi T. Nguyen, Hoon-Ki Paul Min et al. · 2024 · Alzheimer s & Dementia
Peripheral transcriptomic biomarkers for early detection of sporadic Alzheimer disease?
Adva Hadar, David Gurwitz · 2018 · Dialogues in Clinical Neuroscience
Multiplex connectome changes across the alzheimer’s disease spectrum using gray matter and amyloid data
Anna Canal-García, Emiliano Gómez-Ruiz, Mite Mijalkov, Yu-Wei Chang, Giovanni Volpe, Joana B. Pereira, Alzheimer’s Disease Neuroimaging Initiative · 2021 · Cerebral Cortex
β-Amyloid–Dependent and –Independent Genetic Pathways Regulating CSF Tau Biomarkers in Alzheimer Disease
Atul Kumar, Shorena Janelidze, Erik Stomrud, Sebastian Palmqvist, Oskar Hansson, Niklas Mattsson, Alzheimer’s Disease Neuroimaging Initiative · 2022 · Neurology
Associations of cerebrospinal fluid complement proteins with Alzheimer’s pathology, cognition, and brain structure in non-dementia elderly
Meng Li, Ya‐Hui Ma, Yun Guo, Jia-Yao Liu, Lan Tan, on behalf of Alzheimer’s Disease Neuroimaging Initiative · 2024 · Alzheimer s Research & Therapy
Amyloid PET predicts longitudinal functional and cognitive trajectories in a heterogeneous cohort
Kyan Younes, Emily Johns, Christina B. Young, Gabriel Kennedy, Shubhabrata Mukherjee, Hillary A. Vossler, Joseph R. Winer, Karly Alex Cody, Victor W. Henderson, Kathleen L. Poston et al. · 2025 · Alzheimer s & Dementia
Complement C1q is associated with neuroinflammation and mediates the association between amyloid-β and tau pathology in Alzheimer’s disease
Fan Guo, Ze-Hu Sheng, Yan Fu, Zhibo Wang, Rong‐ji Xue, Meng‐Shan Tan, Meng-Shan Tan, Zuo-Teng Wang · 2025 · Translational Psychiatry
Insomnia Moderates the Relationship Between Amyloid-β and Cognitive Decline in Late-Life Adults without Dementia
Wei Xu, Alzheimer’s Disease Neuroimaging Initiative, Chen‐Chen Tan, Juanjuan Zou, Xi‐Peng Cao, Lan Tan · 2021 · Journal of Alzheimer s Disease
Association of Lipidomics Signatures in Blood with Clinical Progression in Preclinical and Prodromal Alzheimer's Disease.
Fatemah A. Sakr, Martin Dyrba, Anja Ursula Bräuer, Stefan Johannes Teipel, Alzheimer’s Disease Neuroimaging Initiative · 2022 · DZNE Pub
Alzheimers Disease Detection Using Different Machine Learning Algorithms
S. Harika, T. Yamini, T. Nagasaikamesh, Shake Hussain Basha, S. Santosh Kumar, Mrs. S. Sri DurgaKameswari · 2022 · International Journal for Research in Applied Science and Engineering Technology
Immediate Reactions to Alzheimer Biomarker Disclosure in Cognitively Unimpaired Individuals in a Global Truncated Randomized Trial
Joshua D. Grill, Rema Raman, Karin B. Ernstrom, Shunran Wang, Michael Donohue, Paul S. S Aisen, Jason H. Karlawish, David B. Henley, Gary J. Romano, Gerald Novak et al. · 2024 · Neurology Clinical Practice
Enhanced Terahertz Specific Sensing for Alzheimer’s Marker by Metasurface-Analyte Union Modification on Microfluidic Sensor
Weinan Shi, Fei Fan, Shanshan Li, Liang Ma, Yiming Wang, Xianghui Wang, Shengjiang Chang · 2024 · IEEE Sensors Journal
Microglial Reactivity Correlates with Presynaptic Loss Independent of β‐Amyloid and Tau
Guoyu Lan, Xuhui Chen, Jie Yang, Pan Sun, Yue Qin Cai, Anqi Li, Yalin Zhu, Zhen Liu, Shaohua Ma, Tengfei Guo et al. · 2024 · Annals of Neurology
Day‐to‐day sleep variability with Alzheimer's biomarkers in at‐risk elderly
Andrée‐Ann Baril, Cynthia Picard, Anne Labonté, Erlan Sanchez, Catherine Duclos, Béry Mohammediyan, Nicholas James Ashton, Henrik Zetterberg, Kaj Blennow, John C.S. Breitner et al. · 2024 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
Plasma Biomarkers as Predictors of Progression to Dementia in Individuals with Mild Cognitive Impairment
Bhargav Teja Nallapu, the Alzheimer’s Disease Neuroimaging Initiative, Kellen K. Petersen, Richard B. Lipton, Christos A. Davatzikos, Ali Ezzati · 2024 · Journal of Alzheimer s Disease
Hypometabolic mismatch with atrophy and tau pathology in mixed Alzheimer’s and Lewy body disease
Michael Tran Duong, Sandhitsu R. Das, Pulkit Khandelwal, Xueying Lyu, Long Xie, Emily McGrew, Nadia Dehghani, Corey T. McMillan, Edward B. Lee, Leslie M. J. Shaw et al. · 2024 · Brain
Plasma proteomic associations with Alzheimer’s disease endophenotypes
Shiva Afshar, Eric B. Dammer, Shijia Bian, David A. Bennett, Richard C. Mohs, Doug Beauregard, John R. Dwyer, Chadwick M. Hales, Felicia C. Goldstein, Monica W. Parker et al. · 2025 · Nature Aging
Effects of baseline serum uric acid and apolipoprotein E4 on longitudinal cognition and cerebral metabolism
Young‐gun Lee, Min-Cheol Park, Seong Ho Jeong, Sung Woo Kang, Kyoungwon Baik, Jin Ho Jung, Phil Hyu Lee, Young H. Sohn, Byoung Seok Ye · 2021 · Neurobiology of Aging
Brain pathology and cognitive scores prior to onset of late‐life depression
Ina S. Almdahl, Ingrid Agartz, Kenneth Hugdahl, Maria Stylianou Korsnes, Alzheimer’s Disease Neuroimaging Initiative · 2022 · International Journal of Geriatric Psychiatry
Accelerated atrophy in dopaminergic targets and medial temporo-parietal regions precedes the onset of delusions in patients with Alzheimer’s disease
Riccardo Manca, Jose Manuel Valera‐Bermejo, Annalena Venneri, Alzheimer’s Disease Neuroimaging Initiative · 2022 · European Archives of Psychiatry and Clinical Neuroscience
Is liquid biopsy mature enough for the diagnosis of Alzheimer’s disease?
Xun Gong, Hantao Zhang, Xiaoyan Liu, Yi Liu, Junlin Liu, Funmilayo Omotoyosi Fapohunda, Peng Lü, Kun Wang, Min Tang · 2022 · Frontiers in Aging Neuroscience
Serum unsaturated phosphatidylcholines predict longitudinal basal forebrain degeneration in Alzheimer’s disease
Hayley R. C. Shanks, Kate M. Onuska, Dinesh Kumar Barupal, Taylor W. Schmitz, Alzheimer’s Disease Neuroimaging Initiative · 2022 · Brain Communications
Improved connectivity and cognition due to cognitive stimulation in Alzheimer’s disease
Qumars Behfar, Nils Richter, Merve Kural, Anne Clemens, Stefan Kambiz Behfar, Ann‐Kristin Folkerts, Ronja V. Fassbender, Elke Kalbe, Gereon R. Fink, Oezguer A. Onur · 2023 · Frontiers in Aging Neuroscience
Comprehensive assessment of fine motor movement and cognitive function among older adults in China: a cross-sectional study
Jie Zhang, Ye-Jing Zhao, Jun-Yi Wang, Han Cui, Shaojie Li, Xue Meng, Rui-Yu Cai, Juan Xie, Su-Ya Sun, Yao Yao et al. · 2024 · BMC Geriatrics
Longer sleep duration and neuroinflammation in at-risk elderly with a parental history of Alzheimer’s disease
Andrée‐Ann Baril, Cynthia Picard, Anne Labonté, Erlan Sanchez, Catherine Duclos, Béry Mohammediyan, John C.S. Breitner, Sylvia Villeneuve, Judes Poirier, Sylvia Villeneuve et al. · 2024 · SLEEP
Impact of amyloid and tau positivity on longitudinal brain atrophy in cognitively normal individuals
Motonobu Fujishima, Yohei Kawasaki, Toshiharu Mitsuhashi, Hiroshi Matsuda, Alzheimer’s Disease Neuroimaging Initiative · 2024 · Alzheimer s Research & Therapy
Timing of Alzheimer's disease biomarker progressions: A two‐decade observational study from the Alzheimer's Disease Neuroimaging Initiative (ADNI)
Tamar Schaap, Pamela Thropp, Duygu Tosun, Alzheimer’s Disease Neuroimaging Initiative · 2024 · Alzheimer s & Dementia
Weight Loss is a Preclinical Signal of Cerebral Amyloid Deposition and Could Predict Cognitive Impairment in Elderly Adults
Wei Xu, Alzheimer’s Disease Neuroimaging Initiative, Fu-Rong Sun, Chen‐Chen Tan, Lan Tan · 2020 · Journal of Alzheimer s Disease
Topographical distribution of Aβ predicts progression to dementia in Aβ positive mild cognitive impairment
Tharick Ali Pascoal, Joseph Therriault, Sulantha Sanjeewa Mathotaarachchi, Min Su Kang, Monica Shin, Andréa Lessa Benedet, Mira Chamoun, Cécile Tissot, Firoza Zubeida Lussier, Sara Mohaddes et al. · 2020 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
Olfaction and Plasma Biomarkers of Alzheimer Disease and Neurodegeneration in the Atherosclerosis Risk in Communities Study
Srishti Shrestha, Xiaoqian Zhu, Michael E Griswold, Priya Palta, Kevin Sullivan, Honglei Chen, Andrea Lauren Christman Schneider, Abhay Moghekar, Megan L. Grove, Bharat Thyagarajan et al. · 2025 · Neurology
Mild behavioural impairment-apathy and core Alzheimer's disease cerebrospinal fluid biomarkers
Daniella Alicia Vellone, Rebeca Leon, Zahra Goodarzi, Nils D. Forkert, Eric Edward Smith, Zahinoor Ismail · 2025 · Brain
Accelerating biomedical discoveries in brain health through transformative neuropathology of aging and neurodegeneration
Melissa Erin Murray, Colin Smith, Vilas Menon, Christopher Dirk Keene, Ed S. Lein, Michael Hawrylycz, Adriano Aguzzi, Brett L. Benedetti, Katja Brose, Kelsey Caetano-Anollés et al. · 2025 · Neuron
CSF total tau as a proxy of synaptic degeneration
Carolina Soares, Bruna Bellaver, Pâmela C.L. Ferreira, Guilherme Povala, Cristiano Schaffer Aguzzoli, João Pedro Ferrari‐Souza, Hussein Zalzale, Firoza Zubeida Lussier, Francieli Rohden, Sarah Abbas et al. · 2025 · Nature Communications
Optimal Combinations of AT(N) Biomarkers to Determine Longitudinal Cognition in the Alzheimer's Disease
Rong-Rong Lin, Yan‐Yan Xue, Xiaoyan Li, Yi-He Chen, Qing‐Qing Tao, Zhi‐Ying Wu · 2021 · Frontiers in Aging Neuroscience
Diagnostic performance of CSF biomarkers in a well-characterized Australian cohort of sporadic Creutzfeldt-Jakob disease
Matteo Senesi, Victoria Lewis, Shiji Varghese, Christiane Stehmann, Amelia R. McGlade, James D. Doecke, Laura J. Ellett, Shannon Sarros, Christopher James Fowler, Colin Louis Masters et al. · 2023 · Frontiers in Neurology
Longitudinal changes in hippocampal texture from healthy aging to Alzheimer’s disease
Alfie R. Wearn, Lars Lau Rakêt, D. Louis Collins, R. Nathan Spreng, Alzheimer’s Disease Neuroimaging Initiative · 2023 · Brain Communications
Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter study
Núria Guillén, José Contador, Maríateresa Buongiorno, Ignacio Álvarez, Natàlia Cullell, Daniel Andres Alcolea, Alberto Lleó, Juan Fortea, Gerard Piñol‐Ripoll, Anna Carnes et al. · 2023 · European Archives of Psychiatry and Clinical Neuroscience
Continuous β-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease Heterogeneity
Sophie E Mastenbroek, Arianna Sala, David Vállez García, Mahnaz Shekari, Gemma Salvadó, Luigi Lorenzini, Leonard Pieperhoff, Alle Meije Wink, Isadora Lopes Alves, Robin Wolz et al. · 2024 · Neurology
CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET
Kwangsik T. Nho, Shannon L. Risacher, Liana G. Apostolova, Paula J. Bice, Jared R. Brosch, Rachael L. Deardorff, Kelley M. Faber, Martin Rhys Farlow, Tatiana Foroud, Sujuan Gao et al. · 2024 · Nature Communications
Detection of early-stage Alzheimer’s pathology using blood-based autoantibody biomarkers in elderly hip fracture repair patients
Cassandra A. DeMarshall, Esther S. Oh, Rahil Kheirkhah, Frederick E. Sieber, Henrik Zetterberg, Kaj Blennow, Robert G. Nagele · 2019 · PLoS ONE
Plasma biomarkers of amyloid, tau & neuroinflammation in Alzheimer’s disease and corticobasal syndrome
Carolin Kurz, Laura Carli, Selim Guersel, Isabelle Schrurs, Alexander Jethwa, Margherita Carboni, Tobias Bittner, Sayuri Hortsch, Daniel Keeser, Matthias Brendel et al. · 2025 · European Archives of Psychiatry and Clinical Neuroscience
Plasma phosphorylated tau 217 and amyloid‑β 42/40 for amyloid risk in subgroups
Heekyoung Kang, Heejin Yoo, Jung‐Ah Lee, Soyeon Yoon, Henrik Zetterberg, Kaj Blennow, Fernando González‐Ortiz, Nicholas James Ashton, Theresa A. Day, Sung Hoon Kang et al. · 2025 · Alzheimer s Research & Therapy
Cognitive Function and Amyloid Marker in Frail Older Adults: The Cogfrail Cohort Study
Sandrine Sourdet, Gaëlle Soriano, Julien Delrieu, Zara Steinmeyer, Sophie Guyonnet, Laure Saint‐Aubert, Pierre Payoux, Pierre‐Jean Ousset, Anne Ghisolfi, Bruno Chicoulaa et al. · 2021 · The Journal of Frailty & Aging
Imaging Biomarkers for Central Nervous System Drug Development and Future Clinical Utility: Lessons from Neurodegenerative Disorders
John Peter Seibyl · 2022 · Journal of Nuclear Medicine
Deep learning for risk-based stratification of cognitively impaired individuals
Michael F. Romano, Xiao Zhou, Akshara R. Balachandra, Michalina F. Jadick, Shangran Qiu, Diya A. Nijhawan, Prajakta S. Joshi, Shariq Mohammad, Peter H. Lee, Maximilian J. Smith et al. · 2023 · iScience
Exploring the significance of lipids in Alzheimer's disease and the potential of extracellular vesicles
Huaqi Su, Colin Louis Masters, Ashley Ian Bush, Kevin Jeffrey Barnham, Gavin E. Reid, Laura J. Vella · 2023 · PROTEOMICS
Association Between Serum Neurofilament Light Chain and Cognitive Performance Among Older Adults in the United States: A Cross-Sectional Study
Yuanyuan Gao, Dan Su, Zhouya Xue, Lin Ji, Shu Wang · 2023 · Neurology and Therapy
Network dysfunction in cognitively normal APOE ε4 carriers is related to subclinical tau
Omar Hameed Butt, Karin L. Meeker, Julie K. Wisch, Suzanne E. Schindler, Anne M. Fagan, Tammie L.S. Benzinger, Carlos Cruchaga, David M. Holtzman, John C. Morris, Beau M. Ances · 2021 · Alzheimer s & Dementia
Cognitive Decline in Parkinson’s Disease: A Subgroup of Extreme Decliners Revealed by a Data-Driven Analysis of Longitudinal Progression
Sara Andersson, Maria Josefsson, Lars Stiernman Jonasson, Anna Rieckmann · 2021 · Frontiers in Psychology
Association Between Plasma Amyloid-β and Neuropsychological Performance in Patients With Cognitive Decline
Jihwan Yun, Hye Jin Kim, Hyug‐Gi Kim, Kyung Mi Lee, Il Ki Hong, Sang Hoon Kim, Hak Young Rhee, Geon‐Ho Jahng, Sung Sang Yoon, Key‐Chung Park et al. · 2021 · Frontiers in Aging Neuroscience
Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy
Anna L. Svenningsson, Erik Stomrud, Sebastian Palmqvist, Oskar Hansson, Rik Ossenkoppele · 2022 · Alzheimer s Research & Therapy
CSF biomarker concordance with amyloid PET in Phase 3 studies of aducanumab
Laura Nisenbaum, Robert L. Martone, Tianle Chen, Raj Rajagovindan, Gersham W. Dent, John D. Beaver, Carrie E. Rubel, Annie Marie Racine, Ping He, Katie Harrison et al. · 2023 · Alzheimer s & Dementia
Arterial Stiffening Moderates the Relationship Between Type-2 Diabetes Mellitus and White Matter Hyperintensity Burden in Older Adults With Mild Cognitive Impairment
Madeleine L. Werhane, Kelsey R. Thomas, Katherine J. Bangen, Alexandra J. Weigand, Emily C. Edmonds, Daniel A. Nation, Erin E. Sundermann, Mark William Bondi, Lisa Delano‐Wood · 2021 · Frontiers in Aging Neuroscience
Machine-learning based strategy identifies a robust protein biomarker panel for Alzheimer’s disease in cerebrospinal fluid
Xiaosen Hou, Yunjie Qiu, Hui Li, Yan Yan, Dongxu Zhao, Simei Ji, Junjun Ni, Jun Zhang, Kefu Liu, Hong Qing et al. · 2025 · Alzheimer s Research & Therapy
Elecsys pTau217 plasma immunoassay detection of amyloid pathology in clinical cohorts
Derrek P. Hibar, Alina Bauer, Christina Rabe, Niels Borlinghaus, Alexander Jethwa, Gwendlyn Kollmorgen, Annunziata Di Domenico, Henrik Zetterberg, Kaj Blennow, Colin Louis Masters et al. · 2026 · Alzheimer s & Dementia
Can T1-Weighted Magnetic Resonance Imaging Significantly Improve Mini-Mental State Examination-Based Distinguishing Between Mild Cognitive Impairment and Early-Stage Alzheimer’s Disease?
Anna Marcisz, Alzheimer’s Disease Neuroimaging Initiative, Joanna Polanska · 2023 · Journal of Alzheimer s Disease
Cerebral Small Vessel Disease Burden Predicts Neurodegeneration and Clinical Progression in Prodromal Alzheimer’s Disease
Yan Sun, Alzheimer’s Disease Neuroimaging Initiative, He‐Ying Hu, Hao Hu, Liangyu Huang, Lan Tan, Jin‐Tai Yu · 2023 · Journal of Alzheimer s Disease
Glucose metabolism in posterior cingulate cortex has supplementary value to predict the progression of cognitively unimpaired to dementia due to Alzheimer’s disease: an exploratory study of 18F-FDG-PET
Qi Zhang, Chunqiu Fan, Luyao Wang, Taoran Li, Min Wang, Ying Han, Jiehui Jiang, and for the Alzheimer’s Disease Neuroimaging Initiative, Michael Walter Weiner, Paul S. S Aisen et al. · 2023 · GeroScience
Association of APOE-ε4 and GAP-43-related presynaptic loss with β-amyloid, tau, neurodegeneration, and cognitive decline
Guoyu Lan, Jing Du, Xuhui Chen, Qingyong Wang, Ying Han, Tengfei Guo · 2023 · Neurobiology of Aging
The role of visual rating and automated brain volumetry in early detection and differential diagnosis of Alzheimer's disease
Yingren Mai, Zhiyu Cao, Lei Zhao, Qun Yu, Jiaxin Xu, Wenyan Liu, Bowen Liu, Jingyi Tang, Yishan Luo, Wang Liao et al. · 2023 · CNS Neuroscience & Therapeutics
Potential role of blood pressure variability and plasma neurofilament light in the mechanism of comorbidity between Alzheimer's disease and cerebral small vessel disease
Qin Li, Shu Su, Yuxue Feng, Meng Jia, Jiehong Zhan, Zixuan Liao, Jiayu Li, Xiaofeng Li, Alzheimer’s Disease Neuroimaging Initiative · 2024 · Alzheimer s & Dementia
Use of anti-amyloid therapies for Alzheimer’s disease in Brazil: a position paper from the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology
Breno José Alencar Pires Barbosa, Elisa de Paula França Resende, Raphael Machado Castilhos, Wyllians Vendramini Borelli, Norberto Anízio Ferreira Frota, Márcio Luiz Figueredo Balthazar, Augusto Celso Scarparo Amato Filho, Jerusa Smid, Maira Tonidandel Barbosa, Artur Martins Coutinho et al. · 2024 · Dementia & Neuropsychologia
Clinical Importance of Amyloid Beta Implication in the Detection and Treatment of Alzheimer’s Disease
Justyna Pokrzyk, Agnieszka Kulczyńska‐Przybik, Ewa Monika Guzik-Makaruk, Izabela Winkel, Barbara Mroczko · 2025 · International Journal of Molecular Sciences
Higher Level of Mismatch in APOE ε 4 Carriers for Amyloid-Beta Peptide Alzheimer’s Disease Biomarkers in Cerebrospinal Fluid
Jonathan S. Vogelgsang, Ruth Vukovich, Dirk Wedekind, Jens Wiltfang · 2019 · ASN NEURO
Gedächtnisambulanzen in Deutschland – strukturell-organisatorische Voraussetzungen und Aufgabenfelder
Lucrezia Hausner, Lutz Frölich, Christine A. F. Von Arnim, Jens Bohlken, Richard C. Dodel, Markus Otto, Michael A. Rapp, Jörg Bernhard Schulz, T. Supprian, Marc Axel Wollmer et al. · 2020 · Der Nervenarzt
Subtle cognitive impairment as a marker of Alzheimer's pathologies and clinical progression in cognitively normal individuals
Xue‐Ning Shen, Kevin Kuo, Yuxiang Yang, Hong‐Qi Li, Shi‐Dong Chen, Mei Cui, Lan Tan, Qiang Dong, Jin‐Tai Yu, Alzheimer’s Disease Neuroimaging Initiative · 2021 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
β-Amyloid discordance of cerebrospinal fluid and positron emission tomography imaging shows distinct spatial tau patterns
Chenyang Jiang, Qingyong Wang, Siwei Xie, Zhicheng Chen, Liping Fu, Qiyu Peng, Ying Liang, Hongbo Guo, Tengfei Guo, Alzheimer’s Disease Neuroimaging Initiative · 2022 · Brain Communications
Moyamoya disease: A human model for chronic hypoperfusion and intervention in Alzheimer's disease
Xiang Zou, Yifan Yuan, Yujun Liao, Conglin Jiang, Fan Zhao, Ding Ding, Yuxiang Gu, Liang Chen, Ying‐Hua Chu, Yi‐Cheng Hsu et al. · 2022 · Alzheimer s & Dementia Translational Research & Clinical Interventions
The Correlation of Tau Levels with Blood Monocyte Count in Patients with Alzheimer’s Disease
Hao-Lun Sun, Fa-Ying Zhou, Dong-Wan Chen, Cheng-Rong Tan, Gui-Hua Zeng, Yu-Hui Liu, Jun Wang, Xian‐Le Bu, Yan-Jiang Wang, Hui-Yun Li et al. · 2021 · Journal of Alzheimer s Disease
The coupling of global brain activity and cerebrospinal fluid flow as a potential predictive marker of brain amyloid-β accumulation
Yuya Tanaka, Koji Kamagata, Yuya Saito, Kaito Takabayashi, Rinako Iseki, Wataru Uchida, Christina Andica, Akifumi Hagiwara, Akihiko Wada, Toshiaki Akashi et al. · 2025 · The Journal of Prevention of Alzheimer s Disease
Neuroinflammation-mediated YKL-40 correlates with tau pathology and predicts longitudinal cognitive impairment and brain atrophy in Alzheimer’s disease, with hypertensive dependency
Ya-Yu Wang, Man Zhang, Shu-Jian Chen, Wei Miao, Zhi-Xin Wang, Yajie Zhou, Siqi Yu, Zhong-Wu Sun, Xia Zhou, Xian-Feng Yu et al. · 2025 · Frontiers in Aging Neuroscience
Basal forebrain activity predicts functional degeneration in the entorhinal cortex in Alzheimer’s disease
Marthe Mieling, Martin Göttlich, Mushfa Yousuf, Nico Bunzeck · 2023 · Brain Communications
The longitudinal trajectory of CSF sTREM2: the alzheimer’s disease neuroimaging initiative
Yu Tian Wang, Meijie Ye, Qianqian Ji, Qi Liu, Xiaowei Xu, Yiqiang Zhan · 2024 · Alzheimer s Research & Therapy
A whole‐brain functional connectivity model of Alzheimer's disease pathology
Ruchika Shaurya Prakash, Michael R. McKenna, Oyetunde Gbadeyan, Anita Shankar, Erika Pugh, James Teng, Rebecca Andridge, Anne S. Berry, Douglas W. Scharre · 2024 · Alzheimer s & Dementia
Practice Effects in Mild Cognitive Impairment Increase Reversion Rates and Delay Detection of New Impairments
Mark E. Sanderson‐Cimino, Jeremy A. Elman, Xin Ming Tu, Alden L. Gross, Matthew S. Panizzon, Daniel E. Gustavson, Mark William Bondi, Emily C. Edmonds, Joel S. Eppig, Carol E. Franz et al. · 2022 · Frontiers in Aging Neuroscience
Associations of plasma angiostatin and amyloid-β and tau levels in Alzheimer’s disease
Yuan Cheng, Jun-Rong Ren, Jie-Ming Jian, Chen-Yang He, Man‐Yu Xu, Gui‐Hua Zeng, Cheng‐Rong Tan, Ying‐Ying Shen, Wang‐Sheng Jin, Dong‐Wan Chen et al. · 2022 · Translational Psychiatry
Initial Data and a Clinical Diagnosis Transition for the Aiginition Longitudinal Biomarker Investigation of Neurodegeneration (ALBION) Study
Nikolaos Scarmeas, Argyro Daskalaki, Faidra Kalligerou, Eva Ntanasi, Eirini Mamalaki, Antonios N. Gargalionis, Kostas Patas, Stylianos Chatzipanagiotou, Mary Yannakoulia, Vasilios C. Constantinides · 2022 · Medicina
Diagnostic performance of automated plasma amyloid-β assays combined with pre-analytical immunoprecipitation
Hans-W. Klafki, Jonathan S. Vogelgsang, Ekaterina Manuilova, Chris Bauer, Alexander Jethwa, Hermann Esselmann, Anke Jahn‐Brodmann, Dirk Osterloh, Ingolf Lachmann, Benedict Breitling et al. · 2022 · Alzheimer s Research & Therapy
Failure to stop autocorrect errors in reading aloud increases in aging especially with a positive biomarker for Alzheimer’s disease.
Tamar H. Gollan, Denis S. Smirnov, David P. Salmon, Douglas Galasko · 2020 · Psychology and Aging
Effects of long-term sleep disruption on cognitive function and brain amyloid-β burden: a case-control study
Jana Thomas, Sharon J. Ooms, Lara J. Mentink, Jan Booij, Marcel G. M. Olde Rikkert, Sebastiaan Overeem, Roy P. C. Kessels, Jurgen A.H.R. Claassen · 2020 · Alzheimer s Research & Therapy
A three‐range approach enhances the prognostic utility of CSF biomarkers in Alzheimer's disease
Wagner Scheeren Brum, Marco Antônio De Bastiani, Andrei Bieger, Joseph Therriault, João Pedro Ferrari‐Souza, Andréa Lessa Benedet, Paramita Saha‐Chaudhuri, Diogo Onofre Souza, Nicholas James Ashton, Henrik Zetterberg et al. · 2022 · Alzheimer s & Dementia Translational Research & Clinical Interventions
Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum
Lian Tang, Zhibo Wang, Lingzhi Ma, Xi‐Peng Cao, Lan Tan, Meng‐Shan Tan · 2022 · BMC Neurology
Cálculo do custo da cesta básica de Vitória da Conquista – BA, no contexto da pandemia do SARS-CoV-2
Darci Rodrigues Alves, Gildásio Santana Júnior, José Vitor Silva Oliveira · 2022 · Cadernos de Ciências Sociais Aplicadas
Hippocampal metabolic subregions and networks: Behavioral, molecular, and pathological aging profiles
Somayeh Maleki Balajoo, Simon Bodo Eickhoff, Shahrzad Kharabian Masouleh, Anna Plachti, Laura K. Waite, Amin Saberi, Mohamed Ali Bahri, Christine Bastin, Éric Salmon, Felix Hoffstaedter et al. · 2023 · Alzheimer s & Dementia
Machine learning prediction of future amyloid beta positivity in amyloid-negative individuals
Elaheh Moradi, Mithilesh Prakash, Anette Hall, Alina Solomon, Bryan Andrew Strange, Jussi Tohka, Alzheimer’s Disease Neuroimaging Initiative · 2024 · Alzheimer s Research & Therapy
Neurodegeneration Biomarkers in Adult Spinal Muscular Atrophy (SMA) Patients Treated with Nusinersen
Pol Andrés‐Benito, Juan Francisco Vazquez-Costa, Nancy Carolina Ñungo Garzón, Maria Jose Colomina, Carla Marco, Laura González, Cristina Terrafeta, Raúl Domínguez, Isidró Ferrer, Mónica Povedano · 2024 · International Journal of Molecular Sciences
Irregular word reading as a marker of semantic decline in Alzheimer’s disease: implications for premorbid intellectual ability measurement
Anna Marier, Mahsa Dadar, Florence Bouhali, Maxime Montembeault, Alzheimer’s Disease Neuroimaging Initiative · 2024 · Alzheimer s Research & Therapy
Serum and CSF biomarkers in asymptomatic patients during primary HIV infection: a randomized study
Andrea Calcagno, Jessica Cusato, Paola Maria Cinque, Giulia Maria Marchetti, Davide Paolo Bernasconi, Mattia Trunfio, Elena Bruzzesi, Stefano Rusconi, Arianna Gabrieli, Antonio Muscatello et al. · 2024 · Brain
Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: an update of the literature
Tina Milos, Barbara Vuić, Nikola Balic, Vladimir Farkaš, Gordana Nedić Erjavec, Dubravka Švob Štrac, Matea Nikolac Perković, Nela Pivac · 2024 · Expert Review of Neurotherapeutics
Biological mechanisms of resilience to tau pathology in Alzheimer’s disease
Anna L. Svenningsson, Diana I. Bocancea, Erik Stomrud, Anita C. van Loenhoud, Frederik Barkhof, Niklas Mattsson, Sebastian Palmqvist, Oskar Hansson, Rik Ossenkoppele · 2024 · Alzheimer s Research & Therapy
Multimodal MRI accurately identifies amyloid status in unbalanced cohorts in Alzheimer’s disease continuum
Giorgio Dolci, Charles A. Ellis, Federica Cruciani, Lorenza Brusini, Anees Abrol, Ilaria Boscolo Galazzo, Gloria Menegaz, Vince D. Calhoun, Alzheimer’s Disease Neuroimaging Initiative · 2024 · Network Neuroscience
Dissecting the clinical and pathological prognosis of MCI patients who reverted to normal cognition: a longitudinal study
Haihong Yu, Lan Tan, Meng-Jiao Jiao, Yi-Ju Lv, Xin-Hao Zhang, Chen‐Chen Tan, Wei Xu, Alzheimer’s Disease Neuroimaging Initiative · 2025 · BMC Medicine